Merck KGaA: An AI-Resistant Pharma Play

Group 1 - The article highlights Merck KGaA as a currently favored undervalued pharmaceutical investment opportunity [1] - The author expresses a beneficial long position in the shares of Merck KGaA and Sanofi, indicating confidence in their potential [1] Group 2 - The article does not provide specific financial metrics or performance data related to Merck KGaA or the pharmaceutical industry [2][3]